Literature DB >> 2827006

Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells.

T D Palella1, L J Silverman, C T Schroll, F L Homa, M Levine, W N Kelley.   

Abstract

The virtually complete deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT) results in a devastating neurological disease, Lesch-Nyhan syndrome. Transfer of the HPRT gene into fibroblasts and lymphoblasts in vitro and into hematopoietic cells in vivo has been accomplished by other groups with retroviral-derived vectors. It appears to be necessary, however, to transfer the HPRT gene into neuronal cells to correct the neurological dysfunction of this disorder. The neurotropic virus herpes simplex virus type 1 has features that make it suitable for use as a vector to transfer the HPRT gene into neuronal tissue. This report describes the isolation of an HPRT-deficient rat neuroma cell line, designated B103-4C, and the construction of a recombinant herpes simplex virus type 1 that contained human HPRT cDNA. These recombinant viruses were used to infect B103-4C cells. Infected cells expressed HPRT activity which was human in origin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827006      PMCID: PMC363149          DOI: 10.1128/mcb.8.1.457-460.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

1.  Latent herpetic infections following experimental viraemia.

Authors:  M L Cook; J G Stevens
Journal:  J Gen Virol       Date:  1976-04       Impact factor: 3.891

2.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus.

Authors:  L W Enquist; G F Vande Woude; M Wagner; J R Smiley; W C Summers
Journal:  Gene       Date:  1979-11       Impact factor: 3.688

4.  Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction.

Authors:  R Adler; J C Glorioso; M Levine
Journal:  J Gen Virol       Date:  1978-04       Impact factor: 3.891

5.  Evidence that neurons harbor latent herpes simplex virus.

Authors:  M L Cook; V B Bastone; J G Stevens
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

6.  Clonal cell lines from the rat central nervous system.

Authors:  D Schubert; S Heinemann; W Carlisle; H Tarikas; B Kimes; J Patrick; J H Steinbach; W Culp; B L Brandt
Journal:  Nature       Date:  1974-05-17       Impact factor: 49.962

7.  Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA.

Authors:  F L Homa; T M Otal; J C Glorioso; M Levine
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

8.  Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

Authors:  J E Seegmiller; F M Rosenbloom; W N Kelley
Journal:  Science       Date:  1967-03-31       Impact factor: 47.728

9.  Human hypoxanthine-guanine phosphoribosyltransferase. Evidence for tetrameric structure.

Authors:  J A Holden; W N Kelley
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

10.  Characterization of the subunit composition of HGPRTase from human erythrocytes and cultured fibroblasts.

Authors:  V I Zannis; L J Gudas; D W Martin
Journal:  Biochem Genet       Date:  1980-02       Impact factor: 1.890

View more
  12 in total

1.  Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.

Authors:  J A Palmer; R H Branston; C E Lilley; M J Robinson; F Groutsi; J Smith; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  The Jeremiah Metzger lecture. Current status of human gene therapy.

Authors:  W N Kelley; T D Palella
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

3.  Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium.

Authors:  T D Southgate; D Bain; L D Fairbanks; A E Morelli; A T Larregina; H A Simmonds; M G Castro; P R Löwenstein
Journal:  Metab Brain Dis       Date:  1999-12       Impact factor: 3.584

4.  Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene.

Authors:  D Y Ho; E S Mocarski; R M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects.

Authors:  S K Thomas; C E Lilley; D S Latchman; R S Coffin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

Authors:  D M Coen; M Kosz-Vnenchak; J G Jacobson; D A Leib; C L Bogard; P A Schaffer; K L Tyler; D M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 7.  Clinical and biochemical aspects of uric acid overproduction.

Authors:  J García Puig; F A Mateos
Journal:  Pharm World Sci       Date:  1994-04-15

Review 8.  Molecular biology of herpes simplex virus type 1 latency in the nervous system.

Authors:  I Steiner; P G Kennedy
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

9.  Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter.

Authors:  J K Andersen; D M Frim; O Isacson; X O Breakefield
Journal:  Cell Mol Neurobiol       Date:  1993-10       Impact factor: 5.046

Review 10.  Cancer gene therapy: principles, problems, and perspectives.

Authors:  F Herrmann
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.